Peptides in the Limelight: US FDA May Ease Restrictions on Several Peptides The Dermatology Digest FDA Compliance for Peptide Therapy and BPC 157 Holt Law BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step